Changes in proteinuria and the associated risks of ischemic heart disease, acute myocardial infarction, and angina pectoris in Korean population
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: Proteinuria is widely used to predict cardiovascular risk. However, there is insufficient evidence to predict how changes in proteinuria may affect the incidence of cardiovascular disease. METHODS: The study included 265,236 Korean adults who underwent health checkups in 2003-2004 and 2007-2008. They were categorized into 4 groups based on changes in proteinuria (negative: negative → negative; resolved: proteinuria ≥1+ → negative; incident: negative → proteinuria ≥1+; persistent: proteinuria ≥1+ → proteinuria ≥1+). We conducted 6 years of follow-up to identify the risks of developing ischemic heart disease (IHD), acute myocardial infarction (AMI), and angina pectoris according to changes in proteinuria. A multivariate Cox proportional-hazards model was used to calculate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for incident IHD, AMI, and angina pectoris. RESULTS: The IHD risk (expressed as HR [95% CI]) was the highest for persistent proteinuria, followed in descending order by incident and resolved proteinuria, compared with negative proteinuria (negative: reference, resolved: 1.211 [95% CI, 1.104 to 1.329], incident: 1.288 [95% CI, 1.184 to 1.400], and persistent: 1.578 [95% CI, 1.324 to 1.881]). The same pattern was associated with AMI (negative: reference, resolved: 1.401 [95% CI, 1.048 to 1.872], incident: 1.606 [95% CI, 1.268 to 2.035], and persistent: 2.069 [95% CI, 1.281 to 3.342]) and angina pectoris (negative: reference, resolved: 1.184 [95% CI, 1.065 to 1.316], incident: 1.275 [95% CI, 1.160 to 1.401], and persistent: 1.554 [95% CI, 1.272 to 1.899]). CONCLUSIONS: Experiencing proteinuria increased the risks of IHD, AMI, and angina pectoris even after proteinuria resolved.
Abstract
OBJECTIVES: Proteinuria is widely used to predict cardiovascular risk. However, there is insufficient evidence to predict how changes in proteinuria may affect the incidence of cardiovascular disease. METHODS: The study included 265,236 Korean adults who underwent health checkups in 2003-2004 and 2007-2008. They were categorized into 4 groups based on changes in proteinuria (negative: negative → negative; resolved: proteinuria ≥1+ → negative; incident: negative → proteinuria ≥1+; persistent: proteinuria ≥1+ → proteinuria ≥1+). We conducted 6 years of follow-up to identify the risks of developing ischemic heart disease (IHD), acute myocardial infarction (AMI), and angina pectoris according to changes in proteinuria. A multivariate Cox proportional-hazards model was used to calculate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for incident IHD, AMI, and angina pectoris. RESULTS: The IHD risk (expressed as HR [95% CI]) was the highest for persistent proteinuria, followed in descending order by incident and resolved proteinuria, compared with negative proteinuria (negative: reference, resolved: 1.211 [95% CI, 1.104 to 1.329], incident: 1.288 [95% CI, 1.184 to 1.400], and persistent: 1.578 [95% CI, 1.324 to 1.881]). The same pattern was associated with AMI (negative: reference, resolved: 1.401 [95% CI, 1.048 to 1.872], incident: 1.606 [95% CI, 1.268 to 2.035], and persistent: 2.069 [95% CI, 1.281 to 3.342]) and angina pectoris (negative: reference, resolved: 1.184 [95% CI, 1.065 to 1.316], incident: 1.275 [95% CI, 1.160 to 1.401], and persistent: 1.554 [95% CI, 1.272 to 1.899]). CONCLUSIONS: Experiencing proteinuria increased the risks of IHD, AMI, and angina pectoris even after proteinuria resolved.
참고문헌 (34)
- "Global atlas on cardiovascular disease prevention and control" (2011)[URL]
- Wong ND, "Epidemiological studies of CHD and the evolution of preventive cardiology", Nat Rev Cardiol, 11, pp.276~289 (2014)
- GBD 2013 Mortality and Causes of Death Collaborators, "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013 : a systematic analysis for the Global Burden of Disease Study 2013", Lancet, 385, pp.117~171 (2015)
- Iseki K, "Risk of developing end-stage renal disease in a cohort of mass screening", Kidney Int, 49, pp.800~805 (1996)
- Cravedi P, "Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease", Br J Clin Pharmacol, 76, pp.516~523 (2013)
- Agrawal V, "Cardiovascular implications of proteinuria : an indicator of chronic kidney disease", Nat Rev Cardiol, 6, pp.301~311 (2009)
- Nagata M, "Prediction of cardiovascular disease mortality by proteinuria and reduced kidney function : pooled analysis of 39, 000 individuals from 7 cohort studies in Japan", Am J Epidemiol, 178, pp.1~11 (2013)
- Chronic Kidney Disease Prognosis Consortium, "Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts : a collaborative meta-analysis", Lancet, 375, pp.2073~2081 (2010)
- Perkovic V, "The relationship between proteinuria and coronary risk : a systematic review and meta-analysis", PLoS Med, 5, pp.e207~ (2008)
- Bakris GL, "Slowing nephropathy progression : focus on proteinuria reduction", Clin J Am Soc Nephrol, 3(Suppl 1), pp.S3~S10 (2008)
- Peng Y, "The influence of body composition on renal function in patients with coronary artery disease and its prognostic significance : a retrospective cohort study", Cardiovasc Diabetol, 15, pp.106~ (2016)
- Imai E, "Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy : a post hoc analysis(ORIENT-blood pressure)", Nephrol Dial Transplant, 31, pp.447~454 (2016)
- Wang A, "Changes in proteinuria and the risk of myocardial infarction in people with diabetes or pre-diabetes : a prospective cohort study", Cardiovasc Diabetol, 16, pp.104~ (2017)
- Schmieder RE, "Changes in albuminuria predict mortality and morbidity in patients with vascular disease", J Am Soc Nephrol, 22, pp.1353~1364 (2011)
- Savarese G, "Reduction of albumin urinary excretion is associated with reduced cardiovascular events in hypertensive and", or diabetic patients. A meta-regression analysis of 32 randomized trials, 2014, pp.172, 403~410
- Araki S, "Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes", Diabetes, 56, pp.1727~1730 (2007)
- Lee J, "Cohort profile : the National Health Insurance Service-National Sample Cohort(NHIS-NSC), South Korea", Int J Epidemiol, 46, pp.e15~ (2017)
- Konno S, "Moderately increased albuminuria is an independent risk factor of cardiovascular events in the general Japanese population under 75 years of age : the Watari study", PLoS One, 10, pp.e0123893~ (2015)
- Hemmelgarn BR, "Relation between kidney function, proteinuria, and adverse outcomes", JAMA, 303, pp.423~429 (2010)
- Pesola GR, "Dipstick proteinuria as a predictor of all-cause and cardiovascular disease mortality in Bangladesh : a prospective cohort study", Prev Med, 78, pp.72~77 (2015)
- Deckert T, "Albuminuria reflects widespread vascular damage. The Steno hypothesis", Diabetologia, 32, pp.219~226 (1989)
- Currie G, "Proteinuria and its relation to cardiovascular disease", Int J Nephrol Renovasc Dis, 7, pp.13~24 (2013)
- Stehouwer CD, "Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes : progressive, interrelated, and independently associated with risk of death", Diabetes, 51, pp.1157~1165 (2002)
- Yilmaz MI, "ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction", J Am Soc Nephrol, 19, pp.388~395 (2008)
- Badimon L, "Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease", Eur Heart J Acute Cardiovasc Care, 1, pp.60~74 (2012)
- Hirano T, "Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients", Diabetes Res Clin Pract, 36, pp.11~18 (1997)
- Knöbl P, "Thrombogenic factors are related to urinary albumin excretion rate in type 1(insulin-dependent)and type 2(non-insulin-dependent)diabetic patients", Diabetologia, 36, pp.1045~1050 (1993)
- Mykkänen L, "Microalbuminuria is associated with insulin resistance in nondiabetic subjects : the insulin resistance atherosclerosis study", Diabetes, 47, pp.793~800 (1998)
- Bianchi S, "Elevated serum insulin levels in patients with essential hypertension and microalbuminuria", Hypertension, 23, pp.681~687 (1994)
- de Boer IH, "Albuminuria changes and cardiovascular and renal outcomes in type 1 diabetes : the DCCT", EDIC study, 2016, pp.11, 1969~1977
- Heerspink HJ, "Renal outcomes with aliskiren in patients with type 2 diabetes : a prespecified secondary analysis of the ALTITUDE randomised controlled trial", Lancet Diabetes Endocrinol, 4, pp.309~317 (2016)
- Harrison TG, "Change in proteinuria or albuminuria as a surrogate for cardiovascular and other major clinical outcomes : a systematic review and meta-analysis", Can J Cardiol, 35, pp.77~91 (2019)
- White SL, "Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community", Am J Kidney Dis, 58, pp.19~28 (2011)
- Konta T, "Clinical utility of trace proteinuria for microalbuminuria screening in the general population", Clin Exp Nephrol, 11, pp.51~55 (2007)